Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.
George GiannakoulasPanagiotis SavvoulidisVasilios GrosomanidisSophia-Anastasia MouratoglouHaralambos KarvounisStavros HadjimiltiadesPublished in: BMC pulmonary medicine (2016)
PH secondary to NF1 may be successfully treated with the combination of atrial septostomy and PH targeted therapy in selected patients.
Keyphrases
- pulmonary hypertension
- end stage renal disease
- atrial fibrillation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- signaling pathway
- oxidative stress
- left atrial
- prognostic factors
- peritoneal dialysis
- stem cells
- pulmonary artery
- immune response
- pulmonary arterial hypertension
- coronary artery
- inflammatory response
- catheter ablation
- pi k akt
- mesenchymal stem cells
- smoking cessation